TITLE

The Institute of Circulatory and Respiratory Health

AUTHOR(S)
Wysong, Pippa
PUB. DATE
October 2002
SOURCE
Clinical & Investigative Medicine;Oct2002, Vol. 25 Issue 5, p178
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Provides information on the Institute of Circulatory and Respiratory Health (ICRH) in Vancouver, British Columbia. Research projects of the ICRH; Joint research initiative of the ICRH, the Canadian Institutes for Health Research and the Canadian Cystic Fibrosis Foundation; Details of the Focus on Stroke Training project of the ICRH.
ACCESSION #
7511619

 

Related Articles

  • Research briefs.  // GP: General Practitioner;7/1/2002, p4 

    Reports developments on medical research as of July 2002 in Great Britain. Decline in the number of deaths due to malignant melanoma; Ratio of adults suffering from a neurotic disorder and mixed anxiety and depression; Side effects of itraconazole and budesonide in treating cystic fibrosis.

  • Lung inflammation: Disarming neutrophils in cystic fibrosis. Leavy, Olive // Nature Reviews Immunology;Jan2008, Vol. 8 Issue 1, p8 

    The article presents a medical research in Great Britain on reducing neutrophils in cystic fibrosis. It is said that the accumulation of neutrophils and high concentrations of the chemokine interleukin-8 (IL-8) in the airways is a characteristic feature of chronic lung diseases. However, further...

  • Respiratory.  // Archives of Disease in Childhood;Apr2006 Supplement, Vol. 91, pA50 

    The article presents abstracts of medical research. They include "Flexible Bronchoscopy and Oesophageal Ph Monitoring in Children Newly Diagnosed With Cystic Fibrosis," "Bacterial Diversity in Sputum From Children With Cystic Fibrosis" and "Audit of Screening and Diagnosis of Cystic Fibrosis...

  • Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation. Clancy, J. P.; Rowe, Steven M.; Accurso, Frank J.; Aitken, Moira L.; Amin, Raouf S.; Ashlock, Melissa A.; Ballmann, Manfred; Boyle, Michael P.; Bronsveld, Inez; Campbell, Preston W.; De Boeck, Kris; Donaldson, Scott H.; Dorkin, Henry L.; Dunitz, Jordan M.; Durie, Peter R.; Jain, Manu; Leonard, Anissa; McCoy, Karen S.; Moss, Richard B.; Pilewski, Joseph M. // Thorax;Jan2012, Vol. 67 Issue 1, p12 

    Background VX-809, a cystic fibrosis transmembrane conductance regulator (CFTR) modulator, has been shown to increase the cell surface density of functional F508del-CFTR in vitro. Methods A randomised, double-blind, placebo-controlled study evaluated the safety, tolerability and pharmacodynamics...

  • Fixing cystic fibrosis CFTR with correctors and potentiators. Off to a good start. Elborn, J. Stuart // Thorax;Jan2012, Vol. 67 Issue 1, p4 

    The author reflects on the results of several studies on treating cystic fibrosis (CF) with correctors and potentiators. He states that numerous in vitro and animal studies suggests that it is possible to correct the cystic fibrosis transmembrane regulator (CFTR) and will make a significant...

  • Probiotic supplementation in children with cystic fibrosis-a systematic review. Ananthan, Anitha; Balasubramanian, Haribalakrishna; Rao, Shripada; Patole, Sanjay // European Journal of Pediatrics;Oct2016, Vol. 175 Issue 10, p1255 

    Unlabelled: Probiotics may benefit in cystic fibrosis (CF) as gut dysbiosis is associated with gastrointestinal symptoms and exacerbation of respiratory symptoms in CF. We conducted a systematic review of randomized controlled trials (RCTs) and non-RCTs of probiotic supplementation...

  • Rare disease day, conference 29.2.2012 - Presentations.  // Acta Facultatis Pharmaceuticae Universitatis Comenianae;2012 Supplement 7, Vol. 59, p9 

    The article discusses several studies including "National Registry for Cystic Fibrosis (CF) in Slovakia" "Slovak Alliance of Rare Diseases (Slovak RD Alliance), " and "Orphan Drugs: The Approach of European and Slovak Regulatory Institutions." These researches feature several rare diseases, and...

  • Method of Classifying Disease Severity May Help Streamline CF Research. Begany, Timothy // Pulmonary Reviews;Nov2006, Vol. 11 Issue 11, p20 

    The article discusses research being done on the significance of classifying disease severity to cystic fibrosis (CF) research. It references a study by M. D. Schluchter and colleagues, published in the 2006 issue of the "American Journal of Respiratory and Critical Care Medicine." It describes...

  • New Technique of Clipless Laparoscopic Cholecystectomy. ElGeidie, Ahmed A. // Surgical Science;Jun2012, Vol. 3 Issue 6, p310 

    Background: In laparoscopic cholecystectomy (LC), application of clips is the standard method for controlling the cystic duct and artery. However, this is not without problems. We propose a modified technique for management of cystic duct and artery in LC. Methods: Since 2007, 328 patients...

  • Cystic Struma Ovarii (With Macrocystic Change). Piragua, Sandra C.; Otis, Christopher N.; Prefontaine, Michel; Pantanowitz, Liron // International Journal of Surgical Pathology;Oct2008, Vol. 16 Issue 4, p433 

    In this article, a case of cystic struma ovarii with macrocystic change is presented. Cysts derived from struma ovarii may mimic a mucinous or serous cystade- noma. A careful examination for any thyroid microfollides within fibrous septa or areas of solid stroma is key. In problematic cases,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics